Financial Management Professionals »

Lineage Cell Therapeutics In shares owned by Financial Management Professionals

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Financial Management Professionals from 13F filings

Historical chart of Financial Management Professionals investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Financial Management Professionals consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Financial Management Professionals

Quarter filed Position value Share count Share price at filing
2026-09-30 $2 2 1.00

More positions owned by Financial Management Professionals

Goldman Sachs Actvbeta US LRG ETF Etf (GSLC)
Dimensional Intern Core EQT MKT ETF Etf (DFAI)
Goldman Sachs Actvbt International Equity ETF Etf (GSIE)
Schwab US Large Cap ETF Etf (SCHX)
John Hancock Multifctr Mid CP ETF Etf (JHMM)
Schwab US Large Cap Value ETF Etf (SCHV)
Pgim Ultra Short Bond ETF Etf (PULS)
iShares Russell 1000 ETF IV Etf (IWB)
Vanguard Total Bond Market ETF Etf (BND)
iShares MSCI USA Multifct ETF Etf (SMLF)
Vanguard Small Cap ETF Etf (VB)
Dimensional Emerging Core Equity Market ETF Etf (DFAE)
Vanguard Value ETF Stock (VTV)
iShares Core MSCI Emerging ETF Etf (IEMG)
Schwab International Equity ETF Etf (SCHF)

View all positions for Financial Management Professionals

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
UBS Group

View all funds holding Lineage Cell Therapeutics In